Healthy ageing: Evidence that improvement is possible at every age

European Geriatric Medicine

Volumn 7, Issue 4, 2016, Pages 298-305

  Michel, J P ^a,b   Dreux, C ^b   Vacheron, A ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Assistance Publique de Paris   (France)

Author keywords

Functioning; Healthy ageing; Life course; Midlife risk factors; Prevention

Indexed keywords

AGING; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EARLY INTERVENTION; EXERCISE; FRAIL ELDERLY; FUNCTIONAL STATUS; HABIT; HEALTH BEHAVIOR; HEALTH STATUS; HEALTHY AGEING; HEARING IMPAIRMENT; HUMAN; KIDNEY DISEASE; LIFE EXPECTANCY; META ANALYSIS (TOPIC); MORTALITY RATE; MULTICENTER STUDY (TOPIC); MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OSTEOARTHRITIS; OSTEOPOROSIS; PHYSICAL DISABILITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTECTION; PSYCHOLOGICAL WELL-BEING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SARCOPENIA; SMELLING DISORDER; SMOKING; SPORT; VACCINATION; VESTIBULAR DISORDER; VESTIBULAR FUNCTION; VISUAL DISORDER; WORLD HEALTH ORGANIZATION;

EID: 84977074023     PISSN: 18787649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurger.2016.04.014     Document Type: Article

References (99)

1. [1] World population prospects: key findings and advance Tables 2015 [database on the Internet]. 2015, Department of Economic and Social affairs.
2. [2] Jagger, C., Trends in life expectancy and healthy life expectancy. 2015.
3. [3] World report on Ageing and Health. 2015, WHO, Geneva.
4. [4] Cecchini, M., Sassi, F., Lauer, J.A., Lee, Y.Y., Guajardo-Barron, V., Chisholm, D., Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376 (2010), 1775–1784.
5. [5] Leskinen, R., Laatikainen, T., Peltonen, M., Levalahti, E., Antikainen, R., Self-reported walking difficulty predicts late-life mortality in Finnish war veterans: results from the Veteran 1992 Project Survey. J Am Geriatr Soc 63 (2015), 118–123.
6. [6] Lange-Maia, B.S., Strotmeyer, E.S., Harris, T.B., Glynn, N.W., Simonsick, E.M., Brach, J.S., et al. Physical activity and change in long distance corridor walk performance in the health, aging, and body composition study. J Am Geriatr Soc 63 (2015), 1348–1354.
7. [7] Hamer, M., Lavoie, K.L., Bacon, S.L., Taking up physical activity in later life and healthy ageing: the English longitudinal study of ageing. Br J Sports Med 48 (2014), 239–243.
8. [8] Bazex, J., Riviere, P.P.D., Les activités physiques et sportives – la santé – la société. Bull Acad Natle Med 196 (2012), 1429–1442.
9. [9] Panagiotakos, D.B., Georgousopoulou, E.N., Pitsavos, C., Chrysohoou, C., Skoumas, I., Pitaraki, E., et al. Exploring the path of Mediterranean diet on 10-year incidence of cardiovascular disease: the ATTICA study (2002–2012). Nutr Metab Cardiovasc Dis 25 (2015), 327–335.
10. [10] Estruch, R., Ros, E., Salas-Salvado, J., Covas, M.I., Corella, D., Aros, F., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 (2013), 1279–1290.
11. [11] Martinez-Lapiscina, E.H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvado, J., San Julian, B., et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 84 (2013), 1318–1325.
12. [12] Huang, J., Walton, K., Gerzoff, R.B., King, B.A., Chaloupka, F.J., State Tobacco Control Program Spending – United States, 2011. MMWR Morb Mortal Wkly Rep 64 (2015), 673–678.
13. [13] Ohara, T., Ninomiya, T., Hata, J., Ozawa, M., Yoshida, D., Mukai, N., et al. Midlife and late-life smoking and risk of dementia in the community: the Hisayama Study. J Am Geriatr Soc 63 (2015), 2332–2339.
14. [14] Dubois, G., Pour un renforcement du contrôle du tabac en France : place des hausses dissuasives et répétées des taxes sur le tabac. Bull Acad Natl Med 196 (2012), 755–757.
15. [15] Britton, A., Ben-Shlomo, Y., Benzeval, M., Kuh, D., Bell, S., Life course trajectories of alcohol consumption in the United Kingdom using longitudinal data from nine cohort studies. BMC Med, 13, 2015, 47.
16. [16] Nordmann, R., Recommandations de l'Académie nationale de médecine concernant les boissons alcooliques : responsabiliser le consommateur. Bull Acad Natl Med 193 (2009), 1181–1184.
17. [17] Muscari, A., Bianchi, G., Conte, C., Forti, P., Magalotti, D., Pandolfi, P., et al. No direct survival effect of light to moderate alcohol drinking in community-dwelling older adults. J Am Geriatr Soc 63 (2015), 2526–2533.
18. [18] Fernandez-Sola, J., Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol 12 (2015), 576–587.
19. [19] World Health Organisation, Global Vaccine Action Plan. 2013, WHO, Geneva.
20. [20] Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
21. [21] Poland, G.A., Belmin, J., Langley, J., Michel, J.P., Van Damme, P., Wicker, S., A global prescription for adult immunization: time is catching up with us. Vaccine 28 (2010), 7137–7139.
22. [22] Lang, P.O., Aspinall, R., Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?. Exp Rev Vaccines 11 (2012), 167–176.
23. [23] van Panhuis, W.G., Grefenstette, J., Jung, S.Y., Chok, N.S., Cross, A., Eng, H., et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med 369 (2013), 2152–2158.
24. [24] Orenstein, W.A., Seib, K., Graham-Rowe, D., Berkley, S., Contemporary vaccine challenges: improving global health one shot at a time. Sci Transl Med, 6(253), 2014, ps11.
25. [25] Davis, M.M., Taubert, K., Benin, A.L., Brown, D.W., Mensah, G.A., Baddour, L.M., et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 48 (2006), 1498–1502.
26. [26] Siriwardena, A.N., Asghar, Z., Coupland, C.C., Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study. Vaccine 32 (2014), 1354–1361.
27. [27] Nagel, M.A., Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol 20 (2014), 157–163.
28. [28] Nagel, M.A., Gilden, D., Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep, 16, 2014, 407.
29. [29] Michel, J.P., Lang, P.O., Promoting life course vaccination. Rejuvenation Res 14 (2011), 75–81.
30. [30] Bourel, M.A.R., Contenu en sel de l'alimentation et hypertension artérielle. Bull Acad Natl Med 188 (2004), 317–329.
31. [31] Vacheron, A., Complications cardiovasculaires du diabète. Bull Acad Natl Med 195 (2011), 205–211.
32. [32] Charpentier, B., Prévention de l'insuffisance rénale chronique. Santé Gdtcdpe, 2015, Académie nationale de médecine, Paris.
33. [33] Bounhoure, J.P., Didier, G.M., Leophonte, A.P., Syndromes d'apnées du sommeil et pathologie cardiovasculaire. Bull Acad Natl Med 189 (2005), 445–465.
34. [34] Lévy, P., Launois, T.R., Pépin, S.J.L., Survivre au sommeil : mourir en dormant ou lorsque le cœur et le cerveau souffrent des apnées. Bull Acad Natl Med 195 (2011), 1611–1634.
35. [35] Kohli, P., Steg, P.G., Cannon, C.P., Smith, S.C. Jr., Eagle, K.A., Ohman, E.M., et al. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. Am J Med 127 (2014), 53e1–60e1.
36. [36] Clarke, R., Emberson, J., Fletcher, A., Breeze, E., Marmot, M., Shipley, M.J., Life expectancy in relation to cardiovascular risk factors: 38-year follow-up of 19,000 men in the Whitehall study. BMJ, 339, 2009, b3513.
37. [37] Plouin, P.F., Bobrie, R.P.G., L'hypertension artérielle du sujet âgé. Bull Acad Natl Med 190 (2006), 793–806.
38. [38] Rachas, A., Raffaitin, C., Barberger-Gateau, P., Helmer, C., Ritchie, K., Tzourio, C., et al. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Heart 98 (2012), 650–655.
39. [39] Reidlinger, D.P., Darzi, J., Hall, W.L., Seed, P.T., Chowienczyk, P.J., Sanders, T.A., et al. How effective are current dietary guidelines for cardiovascular disease prevention in healthy middle-aged and older men and women? A randomized controlled trial. Am J Clin Nutr 101 (2015), 922–930.
40. [40] Reid, R.D., McDonnell, L.A., Riley, D.L., Mark, A.E., Mosca, L., Beaton, L., et al. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial. CMAJ 186 (2014), 23–30.
41. [41] Beckett, N.S., Peters, R., Fletcher, A.E., Staessen, J.A., Liu, L., Dumitrascu, D., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008), 1887–1898.
42. 1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program. BMJ Open Diabetes Res Care, 2, 2014, e000003.
43. [43] Look, A.R.G., Wing, R.R., Bolin, P., Brancati, F.L., Bray, G.A., Clark, J.M., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369 (2013), 145–154.
44. [44] Bousquet, J., Dahl, R., Khaltaev, N., Global alliance against chronic respiratory diseases. Allergy 62 (2007), 216–223.
45. [45] Gibson, G.J., Loddenkemper, R., Lundback, B., Sibille, Y., Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J 42 (2013), 559–563.
46. [46] Bousquet, J., Khaltaev, N., Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases, 2007, World Health Organization [ISBN 978-92-4-156346-8, 48 pp.].
47. [47] Samolinski, B., Fronczak, A., Kuna, P., Akdis, C.A., Anto, J.M., Bialoszewski, A.Z., et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 67 (2012), 726–731.
48. [48] Haahtela, T., Tuomisto, L.E., Pietinalho, A., Klaukka, T., Erhola, M., Kaila, M., et al. A 10-year asthma programme in Finland: major change for the better. Thorax 61 (2006), 663–670.
49. [49] Selroos, O., Kupczyk, M., Kuna, P., Lacwik, P., Bousquet, J., Brennan, D., et al. National and regional asthma programmes in Europe. Eur Respir Rev 24 (2015), 474–483.
50. [50] Bousquet, J., Addis, A., Adcock, I., Agache, I., Agusti, A., Alonso, A., et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44 (2014), 304–323.
51. [51] Norton, S., Matthews, F.E., Barnes, D.E., Yaffe, K., Brayne, C., Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13 (2014), 788–794.
52. [52] Vemuri, P., Lesnick, T.G., Przybelski, S.A., Machulda, M., Knopman, D.S., Mielke, M.M., et al. Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol 71 (2014), 1017–1024.
53. [53] Sofi, F., Valecchi, D., Bacci, D., Abbate, R., Gensini, G.F., Casini, A., et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 269 (2011), 107–117.
54. [54] Ngandu, T., Lehtisalo, J., Solomon, A., Levalahti, E., Ahtiluoto, S., Antikainen, R., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 (2015), 2255–2263.
55. [55] Wolf, P.A., Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol 69 (2012), 567–571.
56. [56] Jones, G., Winzenberg, T.M., Callisaya, M.L., Laslett, L.L., Lifestyle modifications to improve musculoskeletal and bone health and reduce disability – a life-course approach. Best Pract Res Clin Rheumatol 28 (2014), 461–478.
57. [57] Dubousset, J., Vieillissement et chutes. Bull Acad Natl Med, 2014 [serial on the Internet. online (3 juin 2014)].
58. [58] Kemmler, W., Haberle, L., von Stengel, S., Effects of exercise on fracture reduction in older adults: a systematic review and meta-analysis. Osteoporos Int 24 (2013), 1937–1950.
59. [59] Kahan, A., Prévention des maladies musculo-squelettiques. Santé GttcdPe, 2015, Academie nationale de médecine, Paris.
60. [60] Cooper, M.S., Palmer, A.J., Seibel, M.J., Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23 (2012), 97–107.
61. [61] Glyn-Jones, S., Palmer, A.J., Agricola, R., Price, A.J., Vincent, T.L., Weinans, H., et al. Osteoarthritis. Lancet 386 (2015), 376–387.
62. [62] Wandel, S., Juni, P., Tendal, B., Nuesch, E., Villiger, P.M., Welton, N.J., et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ, 341, 2010, c4675.
63. [63] Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P.D., Reginster, J.Y., Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 60 (2009), 524–533.
64. [64] Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
65. [65] Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., Zuniga, C., Arai, H., Boirie, Y., et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43 (2014), 748–759.
66. [66] Swenor, B.K., Simonsick, E.M., Ferrucci, L., Newman, A.B., Rubin, S., Wilson, V., et al. Visual impairment and incident mobility limitations: the health, aging and body composition study. J Am Geriatr Soc 63 (2015), 46–54.
67. [67] Dubousset, J., Posture, équilibre et marche au cours du vieillissement. Santé GCePe, 2015, Académie nationale de médecine, Paris.
68. [68] Dufier, J.L., [Prevention of ocular disease and ageine]. 2015, Personal communication, French National Academy of Medicine, Paris.
69. [69] Tran Ba Huy, P., [Sensory ageing and dependence: balance, hearing and olfaction]. 2015, Personal communication, French National Academy of Medicine, Paris.
70. [70] Bigelow, R.T., Semenov, Y.R., Trevino, C., Ferrucci, L., Resnick, S.M., Simonsick, E.M., et al. Association between visuospatial ability and vestibular function in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc 63 (2015), 1837–1844.
71. [71] Tran Ba Huy, P., Vieillissement sensoriel & dépendance : equilibre, audition et olfaction. Santé GCePe, 2015, Académie nationale de médecine, Paris.
72. [72] Cruickshanks, K.J., Nondahl, D.M., Dalton, D.S., Fischer, M.E., Klein, B.E., Klein, R., et al. Smoking, central adiposity, and poor glycemic control increase risk of hearing impairment. J Am Geriatr Soc 63 (2015), 918–924.
73. [73] Cooper, R., Strand, B.H., Hardy, R., Patel, K.V., Kuh, D., Physical capability in mid-life and survival over 13 years of follow-up: British Birth Cohort Study. BMJ, 348, 2014, g2219.
74. [74] Legrain, S., Mieux prescrire chez le sujet âgé en diminuant l’« underuse », la iatrogénie et en améliorant l'observance. Bull Acad Natl Med 191 (2007), 259–270.
75. [75] Peron, E.P., Gray, S.L., Hanlon, J.T., Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother 9 (2011), 378–391.
76. [76] Dalakas, M.C., Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry 80 (2009), 832–838.
77. [77] O'Neil, C.K., Hanlon, J.T., Marcum, Z.A., Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 10 (2012), 331–342.
78. [78] Ozsvath, K.J., Darling RC3rd, Renal protection: preconditioning for the prevention of contrast-induced nephropathy. Semin Vasc Surg 26 (2013), 144–149.
79. [79] Mehran, R., Aymong, E.D., Nikolsky, E., Lasic, Z., Iakovou, I., Fahy, M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004), 1393–1399.
80. [80] Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., Rockwood, K., Frailty in elderly people. Lancet 381 (2013), 752–762.
81. [81] Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001), M146–M156.
82. [82] Borsch-Supan, A., Brandt, M., Hunkler, C., Kneip, T., Korbmacher, J., Malter, F., et al. Data resource profile: the Survey of Health, Ageing and Retirement in Europe (SHARE). Int J Epidemiol 42 (2013), 992–1001.
83. [83] Santos-Eggimann, B., Cuenoud, P., Spagnoli, J., Junod, J., Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 64 (2009), 675–681.
84. [84] Borrat-Besson, C., RVaWB, 15 Transitions between frailty states – a European comparison. Börsch-Supan, A.B.M., Litwin, H., Weber, G., (eds.) Active ageing and solidarity between generations in Europe, 2014, de Gruyter, 175–186.
85. [85] Gill, T.M., Gahbauer, E.A., Allore, H.G., Han, L., Transitions between frailty states among community-living older persons. Arch Int Med 166 (2006), 418–423.
86. [86] Lee, J.S., Auyeung, T.W., Leung, J., Kwok, T., Woo, J., Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc 15:4 (2014), 281–286, 10.1016/j.jamda.2013.12.002 [Epub 2014 Feb 16].
87. [87] Michel, J.P., Cruz-Jentoft, A.J., Cederholm, T., Frailty, exercise and nutrition. Clin Geriatr Med 31 (2015), 375–387.
88. [88] Tieland, M., Borgonjen-Van den Berg, K.J., van Loon, L.J., de Groot, L.C., Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur J Nutr 51 (2012), 173–179.
89. [89] Tieland, M., Dirks, M.L., van der Zwaluw, N., Verdijk, L.B., van de Rest, O., de Groot, L.C., et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 13 (2012), 713–719.
90. [90] Kim, C.O., Lee, K.R., Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study. J Gerontol A Biol Sci Med Sci 68 (2013), 309–316.
91. [91] Chou, C.H., Hwang, C.L., Wu, Y.T., Effect of exercise on physical function, daily living activities, and quality of life in the frail older adults: a meta-analysis. Arch Phys Med Rehab 93 (2012), 237–244.
92. [92] Gine-Garriga, M., Roque-Figuls, M., Coll-Planas, L., Sitja-Rabert, M., Salva, A., Physical exercise interventions for improving performance-based measures of physical function in community-dwelling, frail older adults: a systematic review and meta-analysis. Arch Phys Med Rehab 95 (2014), 753e3–769e3.
93. [93] Pahor, M., Guralnik, J.M., Ambrosius, W.T., Blair, S., Bonds, D.E., Church, T.S., et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 311 (2014), 2387–2396.
94. [94] Kim, H., Suzuki, T., Kim, M., Kojima, N., Ota, N., Shimotoyodome, A., et al. Effects of exercise and milk fat globule membrane (MFGM) supplementation on body composition, physical function, and hematological parameters in community-dwelling frail Japanese women: a randomized double blind, placebo-controlled, follow-up trial. PLoS One, 10, 2015, e0116256.
95. [95] Cameron, I.D., Fairhall, N., Langron, C., Lockwood, K., Monaghan, N., Aggar, C., et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med, 11, 2013, 65.
96. [96] Fairhall, N., Sherrington, C., Kurrle, S.E., Lord, S.R., Lockwood, K., Cameron, I.D., Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial. BMC Med, 10, 2012, 120.
97. [97] Spoorenberg, S.L., Uittenbroek, R.J., Middel, B., Kremer, B.P., Reijneveld, S.A., Wynia, K., Embrace, a model for integrated elderly care: study protocol of a randomized controlled trial on the effectiveness regarding patient outcomes, service use, costs, and quality of care. BMC Geriatr, 13, 2013, 62.
98. [98] Cesari, M., Demougeot, L., Boccalon, H., Guyonnet, S., Vellas, B., Andrieu, S., The Multidomain Intervention to preveNt disability in ElDers (MINDED) project: rationale and study design of a pilot study. Contemp Clin Trials 38 (2014), 145–154.
99. [99] Rodriguez-Manas, L., Bayer, A.J., Kelly, M., Zeyfang, A., Izquierdo, M., Laosa, O., et al. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes – the MID-Frail study: study protocol for a randomised controlled trial. Trials, 15, 2014, 34.